type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Inuyama Chuo General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients with type 2 diabetes whose 24-h sensor glucose levels (SG) were measured during hospitalization using a continuous glucose monitor (iPro2)
Exclusion criteria
Exclusion criteria: judged to be unsuitable for participation for medical reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relationship between each extraction and every 5 min in following glycemic variability metric values calculated Percentage of time in target range (70~180 mg/dL) Mean absolute glucose (MAG) Glycemic variability percentage (GVP) Mean glucose level Standard deviation (SD) Coefficient of variation (CV) | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycemic variability metric values calculated in measurement every 5 min and each extraction | — |
Countries
Japan
Contacts
Public ContactSoichi Takeishi
Inuyama Chuo General Hospital Diabetes
Outcome results
None listed